Evidence map›Paper›PMID 32457363›Full record

ArticleBritish journal of cancer2020

Producing the appropriate model and drug for intratumoural ablation.

Christoforos Kosmidis, Chrysanthi Sardeli, Paul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Anastasios Vagionas, Nikolaos Ioannis-Katsios, Konstantinos Sapalidis

Open access · hybridAbstract readEditorialComment
In one paragraph

Article in British journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Christoforos Kosmidis3rd University General Department, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Chrysanthi SardeliDepartment of Pharmacology & Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Paul Zarogoulidis3rd University General Department, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. pzarog@hotmail.com.
Wolfgang Hohenforst-SchmidtSana Clinic Group Franken, Department of Cardiology/Pulmonology/Intensive Care/Nephrology, 'Hof' Clinics, University of Erlangen, Hof, Germany.
Anastasios VagionasOncology Department, General Hospital of Kavala, Kavala, Greece.
Nikolaos Ioannis-Katsios3rd University General Department, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantinos SapalidisSana Clinic Group Franken, Department of Cardiology/Pulmonology/Intensive Care/Nephrology, 'Hof' Clinics, University of Erlangen, Hof, Germany.
Aristotle University of Thessaloniki · GRSana Klinikum · DEAHEPA University Hospital · GRTechnological Educational Institute of Eastern Macedonia and Thrace · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Local treatment is necessary for several cancer patients. There are situations where cancer tissue induces locally severe symptoms. Therefore, additional local disease control is necessary. There are two major issues for efficient local treatment: the method of application and the penetration of the drug formulation. We need efficient tools to guide the drug formulation to the target point, and an effective drug formulation that is diffused within the tumour microenvironment with a sustained-release effect.

Indexed as

HydrogelsLung NeoplasmsAnimalsHeterograftsHumansMiceTumor MicroenvironmentHydrogels

Identifiers

PMID32457363
PMCPMC7403372
OpenAlexW3032545400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.